FB-1003

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameFB-1003
Drug Alias NameFB1003FB-1003
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionNerve growth factor receptor Trk-A modulators
TargetsNerve growth factor receptor Trk-A
Therapy Area/IndicationsChronic PainPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaIND
Originator Companies4b Technologies (Suzhou) Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active Companies4b Technologies (Suzhou) LtdFubei Pharmaceutical Technology (Shanghai) Co LtdFubei Biomedical Technology (Beijing) Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsChronic PainPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A